In June 2011, Nicole Susanne Ferrari, received news that would forever change the lives of her and her family; she was diagnosed with ALS. At the age of 39, Nicole had already survived open heart surgery and thought her biggest challenge was behind her. Little did she know she was just starting the fight of her life. Faced with a grim prognosis, most people would give up, but Nicole vowed to Never Stop Fighting.
Together, Nicole and her husband Mike, have become actively involved in the fight to find a cure for ALS. Nicole has participated in over 10 clinical trials through Massachusetts General Hospital and Mike has raised over $50,000 for ALS as a member of the ALS Association and ALS ONE running teams. Their unwavering commitment to one another and their positive attitude is an inspiration to all who know them.
To help advance the progress towards finding a cure for ALS by supporting critical research initiatives, and to support programs that improve the quality of life for people living with ALS now.
Nicole and Mike's family and friends are the driving force behind Team NSF. Their unconditional love and support have given Nicole and Mike the strength to fight each day. From meal deliveries to fundraising to driving Nicole to doctor's appointments, the team has been by their side every step of the way. Together, they are Team NSF and are dedicated to helping find a cure for ALS and improving the quality of life for people living with the disease.
Team NSF has partnered with ALS ONE, an organization that has united the ALS community in three critical areas: Research, Care, and Fundraising. ALS ONE is a partnership of top ALS experts from leading institutions, including Nicole's neurologist, the world-renowned Dr. Merit Cudkowicz and her team at Massachusetts General Hospital, Dr. Robert Brown and his team at The University of Massachusetts Medical Center, ALS Therapy Development Institute, and Compassionate Care ALS. The approach of ALS ONE is to leverage the expertise from each of the research institutions through the sharing of ideas and responsibilities, in order to advance each of the strongest therapeutic opportunities identified, while simultaneously working to improve the quality of life for those living with ALS now.